Ada ist ein persönlicher Gesundheitsbegleiter, der von KI angetrieben wird. Von Ärzten entwickelt, hilft Ada Ihnen, Ihre Symptome zu verstehen und herauszufinden, was die Ursache sein könnte. Es bietet einen intelligenten Symptom-Checker und eine umfassende medizinische Bibliothek, um bessere Gesundheitsentscheidungen und -ergebnisse zu unterstützen.
MedUp ist eine kostenlose, KI-gestützte medizinische Enzyklopädie, die vertrauenswürdige Gesundheitsinformationen basierend auf WHO- und klinischen Richtlinien bereitstellt. Beschreiben Sie Ihre Symptome per Text, Sprache oder Foto, um sofort detaillierte Informationen über mögliche Erkrankungen, Behandlungen und empfohlene Spezialisten zu erhalten. Es dient Bildungszwecken, um Ihnen zu helfen, fundierte Gesundheitsentscheidungen zu treffen.
Produktübersicht
Ada Produktübersicht
Ada ist ein persönlicher Gesundheitsbegleiter, der von KI angetrieben wird. Von Ärzten entwickelt, hilft Ada Ihnen, Ihre Symptome zu verstehen und herauszufinden, was die Ursache sein könnte. Es bietet einen intelligenten Symptom-Checker und eine umfassende medizinische Bibliothek, um bessere Gesundheitsentscheidungen und -ergebnisse zu unterstützen.
MedUp Produktübersicht
MedUp ist eine kostenlose, KI-gestützte medizinische Enzyklopädie, die vertrauenswürdige Gesundheitsinformationen basierend auf WHO- und klinischen Richtlinien bereitstellt. Beschreiben Sie Ihre Symptome per Text, Sprache oder Foto, um sofort detaillierte Informationen über mögliche Erkrankungen, Behandlungen und empfohlene Spezialisten zu erhalten. Es dient Bildungszwecken, um Ihnen zu helfen, fundierte Gesundheitsentscheidungen zu treffen.
Detailed feature comparison
| Feature | Ada | MedUp |
|---|---|---|
| Hauptkategorie | Gesundheit | Medizinische Informationen |
| Hinzugefügt | 2025-08-16 | 2025-08-02 |
| Preismodell | Kostenlos | Kostenlos |
| Offizielle Website | ada.com | www.medup.tech |
| Produkttyp | App | Website |
| Performance data | ||
| Nutzerbewertung | Nicht verifiziert | Nicht verifiziert |
| Kommentare | 0 | 0 |
| Monatliche Besuche | 501.4K | 3.5K |
| Monatliches Wachstum | -4.6% | Nicht verifiziert |
| Favoriten | 133 | 110 |
| Details | Details ansehen | Details ansehen |
Ada vs MedUp monthly traffic
Compare Ada and MedUp by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the Ada vs MedUp monthly traffic comparison, Ada currently shows 501.4K visits and MedUp shows 3.5K; Ada has about 143.3 times the visible traffic of MedUp, an absolute difference of about 497.9K visits. This reflects visible reach, not feature quality or paid users.
Only Ada has complete third-party traffic details; MedUp uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
Ada monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 894.8K Monatliche Besuche
- 2026/1: 752K Monatliche Besuche
- 2026/2: 661.8K Monatliche Besuche
- 2026/3: 622K Monatliche Besuche
- 2026/4: 525.7K Monatliche Besuche
- 2026/5: 501.4K Monatliche Besuche
Top-Regionen
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 47.6% | 238.7K |
| 🇸🇦Saudi Arabia | 20.09% | 100.7K |
| 🇩🇪Germany | 18.72% | 93.9K |
| 🇨🇦Canada | 6.86% | 34.4K |
| 🇧🇷Brazil | 6.73% | 33.7K |
Traffic-Quellen
| Source type | Percentage | Traffic |
|---|---|---|
| Direkt | 82.65% | 414.4K |
| Verweis | 14.79% | 74.2K |
| 2.56% | 12.8K |
Suchbegriffe
MedUp monthly traffic:
Latest traffic
Usage comparison
Compare the core capabilities of Ada and MedUp
Ada Core features
MedUp Core features
Use cases
Ada Use cases
MedUp Use cases
Ada vs MedUp:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth Ada vs MedUp comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Ada is primarily listed under “Gesundheit”, while MedUp is primarily listed under “Medizinische Informationen”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Ada: Gesundheit; MedUp: Medizinische Informationen); Product type (Ada: App; MedUp: Website); Monthly visits (Ada: 501.4K; MedUp: 3.5K); Favorites (Ada: 133; MedUp: 110); Website (Ada: ada.com; MedUp: www.medup.tech). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the Ada vs MedUp monthly traffic comparison, Ada currently shows 501.4K visits and MedUp shows 3.5K; Ada has about 143.3 times the visible traffic of MedUp, an absolute difference of about 497.9K visits. This reflects visible reach, not feature quality or paid users.
Only Ada has complete third-party traffic details; MedUp uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
Ada and MedUp currently overlap in shared categories: Symptom-Checker; shared tags: KI-Arzt, Gesundheitsassistent und Symptom-Checker. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Ada's unique categories/tags are Gesundheit, Persönlicher Assistent, Diagnoseassistent, Gesundheitswesen, Medizinische KI, medizinische Bibliothek und persönliche Gesundheit; MedUp's are Medizinische Informationen, Forschungsassistent, Kostenloses Gesundheitstool, Gesundheitserziehung, medizinische Enzyklopädie, medizinische Informationen und Symptomanalyse. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
Ada has no verified rating, 0 comments, 133 favorites, and 158 likes;MedUp has no verified rating, 0 comments, 110 favorites, and 115 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate Ada first
Put Ada on the priority trial list when the task aligns with “Gesundheit” and especially Gesundheit, Persönlicher Assistent, Diagnoseassistent, Gesundheitswesen, Medizinische KI und medizinische Bibliothek. This follows recorded positioning and does not imply unlisted capabilities are absent.
Ada also currently records: pricing is free, product type is app, 501.4K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate MedUp first
Put MedUp on the priority trial list when the task aligns with “Medizinische Informationen” and especially Medizinische Informationen, Forschungsassistent, Kostenloses Gesundheitstool, Gesundheitserziehung, medizinische Enzyklopädie und medizinische Informationen. This follows recorded positioning and does not imply unlisted capabilities are absent.
MedUp also currently records: pricing is free, product type is website, 3.5K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Ada and MedUp, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




